Weekly News Recap #Phispers
FDA grants accelerated nod to Boehringer’s lung cancer med; reinstates ousted CBER chief Vinay Prasad
The US Food and Drug Administration (FDA) has granted an accelerated approval to Boehringer Ingelheim’s Hernexeos (zonger...
Impressions : 1866
FDA safety review to hold up Moderna’s vaccine for teens; FDA raises concerns at Biocon’s Malaysia site
This
week, Phispers has more updates from Merck. The drugmaker has temporarily
withdrawn its pre-merger notification and repo...
Impressions : 1284
Trump admin wants to pull global supply chains out of China; FDA okays remdesivir for emergency use
This week, Phispers has news on remdesivir, Gilead’s investigational antiviral drug.
The USFDA has issued an emergency ...
Impressions : 67091
Another massive explosion in a chemical plant rocks China; Lilly discloses drug pricing data for insulin
This week, Phispers brings news that
J&J and Bayer have settled more than 25,000 lawsuits in the US against
their blood t...
Impressions : 1936
Aurobindo’s sartan banned in Europe; Dr. Reddy’s cost optimization drive continues, sells off another site
This week, Phispers brings you news from Dr. Reddy’s Laboratories in India which is divesting its API plant in Hyderabad ...
Impressions : 3870
Teva to exit 80 percent generics portfolio in US; Takeda clinches Shire for US$ 62 billion
This week in Phispers, we report on the biggest deal of 2018 yet — Takeda’s acquisition of Shire — that would...
Impressions : 6512
- Privacy policy
- Terms and conditions
- Disclaimers
-
- Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.